Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 78.6%
Negative

Neutral
Seeking Alpha
24 days ago
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Cibus, Inc. (CBUS) Q1 2026 Earnings Call Transcript
Neutral
Zacks Investment Research
24 days ago
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.33 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to a loss of $0.74 per share a year ago.
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
Positive
MarketBeat
24 days ago
Cibus Q1 Earnings Call Highlights
Cibus NASDAQ: CBUS reported first-quarter 2026 results and said it is advancing toward commercialization across its rice and sustainable ingredients programs, while also reducing expenses and extending its cash runway into late in the first quarter of 2027.
Cibus Q1 Earnings Call Highlights
Neutral
GlobeNewsWire
24 days ago
Cibus Reports First Quarter Financial Results and Provides Business Update
SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced its financial results for the quarter ended March 31, 2026, and provided a business update. Management will host a conference call and webcast today at 4:30 p.m.
Cibus Reports First Quarter Financial Results and Provides Business Update
Positive
Zacks Investment Research
1 month ago
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
Cibus (CBUS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
Neutral
GlobeNewsWire
1 month ago
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
Represents achievement of strategic milestone for Cibus' anticipated first commercial offering in the South American market Represents achievement of strategic milestone for Cibus' anticipated first commercial offering in the South American market
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
Neutral
GlobeNewsWire
1 month ago
Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call
SAN DIEGO, April 30, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report first quarter 2026 financial results on Thursday, May 14, 2026. Cibus' management team will host a conference call and audio webcast at 4:30 p.m.
Cibus to Report First Quarter 2026 Financial Results on May 14, 2026 After the Market Close and Host Conference Call
Neutral
GlobeNewsWire
1 month ago
Cibus Announces the Election of Thomas Urban to Board of Directors
SAN DIEGO, April 15, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the election of Thomas Urban to its Board of Directors.
Cibus Announces the Election of Thomas Urban to Board of Directors
Neutral
GlobeNewsWire
2 months ago
Cibus, Inc. Investigated by the Portnoy Law Firm
LOS ANGELES, April 08, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cibus , Inc. , (“ Cibus " or the "Company") ( NASDAQ : CBUS ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.
Cibus, Inc. Investigated by the Portnoy Law Firm
Neutral
GlobeNewsWire
2 months ago
Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock
SAN DIEGO, March 26, 2026 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced the pricing of an underwritten public offering (the “Offering”) of 6,976,744 shares of its Class A Common Stock, par value $0.0001 per share (“Class A Common Stock”) at a purchase price of $2.15 per share of Class A Common Stock.
Cibus, Inc. Announces Pricing of Public Offering of Class A Common Stock